Appendix PP Regulatory Updates - 2025 On-Demand Workshop-F757 Drug Regimen Is Free from Unnecessary Drugs

Video Transcription

Video Summary

This presentation reviews the 2025 updates to Appendix PP's F-757 regulation ensuring that each resident's drug regimen is free from unnecessary medications. Unnecessary drugs are defined by excessive dose, duration, duplicate therapy, inadequate indications, poor monitoring, or adverse effects. The guidance emphasizes comprehensive evaluation of residents' physical, behavioral, and psychosocial conditions, requiring proper documentation of medication rationale and resident consent. A major change is the removal of psychotropic medication requirements from F-757, now under F-605. Facilities must monitor for adverse consequences, reevaluate medications during care transitions, and ensure resident participation in treatment decisions. The American Geriatric Society's updated BEERS criteria is highlighted for safe prescribing in the elderly. Surveyors use updated protocols to assess compliance, focusing on monitoring, documentation, and appropriate medication management. Facility leaders are encouraged to update policies, conduct audits, and educate staff on medication use, documentation, adverse event recognition, and resident rights to maintain compliance with these regulations.

Keywords

Appendix PP 2025 updates

F-757 regulation

unnecessary medications

psychotropic medication F-605

American Geriatric Society BEERS criteria

medication management compliance